Introduction
Peritoneal dialysis (PD) is one of the important renal replacement therapies (RRT). However, PD patients often have to stop their PD therapy and transfer to other RRT (hemodialysis or kidney transplantation), because of their peritoneal membrane dysfunction, ultrafiltration (UF) failure, or refractory peritonitis. Mizuno et al. 1 assessed the duration of PD therapy and causes of withdrawal from PD therapy based on the database from 13 institutions (including our hospital) in the Tokai area of Japan. In this report, 174 of 561 patients withdrew PD therapy during [2005] [2006] [2007] , and 51.9% of patients withdrew within 3 years of starting PD, 16.4% withdrew from 3 to 5 years, and 32.7% withdrew after 5 years. One of the important factors for withdrawal was PD-related peritonitis (27.0%). Other important factors were dialysis failure/UF failure (21.3%) and prevention of encapsulating peritoneal sclerosis (EPS) (19.1%). These are also important withdrawal factors for all PD patients. After discontinuation of PD, PD catheter may have no role for patients, and it will be removed. However, we have to consider the timing of PD catheter removal, especially when withdrawal causes are dialysis failure/UF failure and for the prevention of EPS. In this article, we will discuss adequate timing of PD catheter removal after PD therapy discontinuation.
PD-related peritonitis and exit-site infection
International Society for Peritoneal Dialysis (ISPD) Peritonitis Recommendations 2016, 2 Indications for PD catheter removal are as follows: refractory peritonitis, relapsing peritonitis, refractory exit-site and tunnel infection, fungal peritonitis, and catheter removal may also be considered for repeat peritonitis, mycobacterial peritonitis, and multiple enteric organisms. PD catheter will often become one of the obstacles to the successful treatment for these PD-related infectious diseases. Therefore, when patients stop their PD therapy and transfer to other RRT because of these infectious diseases, we usually remove PD catheter as soon as possible. In these situations, the timing of PD catheter removal is equal to the timing of PD discontinuation.
Dialysis failure/UF failure and prevention of EPS
If patients stop their PD therapy caused by dialysis failure/ UF failure or long-term PD therapy, we have usually moratorium to remove PD catheter after PD discontinuation. After PD discontinuation, we have to follow up the occurrence of EPS. EPS is a rare but important adverse event of PD therapy and often occurs after PD discontinuation. EPS shows many abdominal symptoms like nausea, vomiting, apatite loss, and constipation followed by ileus and malnutrition, and sometimes it can develop into life-threatening condition.
Many parameters were suspected to be risk factors for EPS, for example, higher dialysate glucose exposure, the use of conventional PD solutions (acidic and higher glucose degradation products (GDPs) contained solutions), frequent or severe peritonitis, higher peritoneal permeability, vascular endothelial cell injury of peritoneum, and so on. [3] [4] [5] [6] [7] [8] [9] Especially, longer PD period is suspected to be the most important risk factor for EPS. 5, 6, [10] [11] [12] [13] To prevent EPS, it is recommended to minimize dialysate glucose exposure, prevent acute PD-related peritonitis using interventions recommended by the ISPD peritonitis guidelines, 2 and to use neutral-pH, low-GDP dialysis solutions recommended by the ISPD guidelines in 2017. 13 Based on these information, if long-term PD patients have any high risk of PD technique failure such as high and rising peritoneal permeability, low UF capacity, difficulty in fluid balance control, requirement for high glucose concentration dialysate, and frequent episodes of peritonitis, we can consider PD discontinuation in these patients to reduce the risk of EPS. 13 However, it is unclear whether such PD discontinuation is effective to reduce the risk of EPS or not. In Japanese Society for Dialysis Therapy (JSDT) Guidelines for PD, 14 it is recommended to evaluate PD discontinuation with due consideration of the risk of development of EPS, if progression of peritoneal deterioration is confirmed in patients with long-term PD or after peritonitis. It is also recommended to routinely perform the peritoneal equilibration test (PET) to evaluate peritoneal deterioration.
Many Japanese investigators reported the effect of peritoneal lavage to reduce the risk of EPS. [15] [16] [17] [18] [19] The method of peritoneal lavage is washing peritoneal cavity with saline or low-glucose PD solutions for several months (in some cases, over years) after PD discontinuation. Yamamoto et al. analyzed 247 patients with PD discontinuation for the effect of peritoneal lavage in prevention of EPS. Compared with non-lavage group, the incidence of EPS in lavage group was significantly decreased. 19 However, opposite results were also reported. 10, 20, 21 Kawanishi reported that peritoneal lavage was not effective to prevent EPS, but only delayed the onset of EPS. 20, 21 Therefore, there is no evidence for peritoneal lavage to prevent EPS at present.
Preservation of PD catheter after PD discontinuation has another role despite no evidence of peritoneal lavage. We can assess the changes of peritoneal function or permeability after PD discontinuation using preserved catheter. The monitoring of peritoneal function is important because most EPS occur after stopping PD therapy. 14 Improved dialysate/plasma creatinine (D/P Cr) levels or other clinical data from the drained PD solutions may support our decision of PD catheter removal, especially in patients with high risk of EPS, 22 but we should consider the risk of PD catheter-related infections in this situation. We will present a case of PD discontinuation and the change of D/P Cr levels before and after PD discontinuation.
Case
A 70-year-old male started PD therapy in 2012. His cause of end-stage kidney disease (ESKD) was diabetic nephropathy. In 2012, he suffered from PD related-peritonitis, but his peritonitis was improved immediately. In 2014, he experienced refractory tunnel infection. We removed his old catheter and inserted a new PD catheter. From 2015 to 2017, his D/P Cr level was increasing to high PET category (Figure 1) . We discussed about the risk of EPS with him and decided to stop PD therapy and transfer to hemodialysis therapy. After PD discontinuation, we preserved his PD catheter and treated him with peritoneal lavage every hemodialysis day. We also monitored the volume of ascites. After 2 months from PD discontinuation, the volume of ascites decreased to below 50 mL, and his D/P Cr level also decreased to high average category. At that time, we removed his PD catheter. Now he has no symptoms and no abnormal data suspected to EPS.
Conclusion
Many PD patients transfer to HD therapy for various reasons such as PD-related infectious diseases, UF failure, or longer period of PD. When stopping PD caused by PD-related infectious diseases, the timing of PD catheter removal is equal to the timing of PD discontinuation. When stopping PD caused by UF failure with low risk of EPS, we can remove PD catheter at the same time of PD discontinuation. On the contrary, when stopping PD caused by UF failure with high risk of EPS or long-term PD (prevention for EPS), we can preserve PD catheter and assess the changes of peritoneal function (Figure 2 ). However, we do not have enough evidences for mechanisms, risk factors, prevention, diagnosis, and treatment for EPS and also for decision making of the timing of PD catheter removal. More studies are needed to resolve these problems. 
